The ‘Risk Communication on Medicines Workshop’ organised by the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) took place on 16 and 17 June in Madrid. The event brought together pharmacovigilance and communication experts from national medicines agencies, and representatives from WHO, EMA, EAMI, academia, patients, consumers, and healthcare professionals. In total 103 delegates participated in the meeting which was designed to share the results of Work Package 6- Risk Communication, and discuss how EU national agencies can improve their communication on the risk associated to medicines.
The workshop was a huge success with great contribution from all participants throughout the two days. Work Package 6 presented a vision of shaping the communication in pharmacovigilance for the future by:
- evidence -based use of risk communication practices and tools
- maximising new mechanisms and media
- working in partnership with patients, healthcare professionals and academia
- delivering measurable public health benefits
Videos from the workshop:
Report from the workshop:
This report presents a summary of presentations, breakout sessions, and panel discussions.
Click here to access this report. (17 pages PDF.)
Presenations from the workshop:
Day 1 - 16 June 2016:
Day 2 - 17 June 2016: